---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007320"
form_type: "8-K"
ticker: "RCUS"
cik: "0001724521"
company_name: "Arcus Biosciences, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:38:06.525399+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcus Biosciences appoints Alexander Azoy as Principal Accounting Officer

## Summary
- Alexander Azoy appointed Principal Accounting Officer effective March 9, 2023.
- Robert C. Goeltz II remains CFO but ceases as Principal Accounting Officer.
- Azoy previously VP of Finance since Oct 2020; prior CFO at Sienna Biopharmaceuticals.
- Azoy entered standard severance/change of control agreement and severance program.

## SEC filing metadata
- accession: 0000950170-23-007320
- form_type: 8-K
- ticker: RCUS
- cik: 0001724521
- company_name: Arcus Biosciences, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/rcus-20230309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007320
- JSON: https://secwatch.observer/filing/0000950170-23-007320.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007320.txt

## Key facts
- Executive change
  Robert C. Goeltz II changed role as Principal Accounting Officer at Arcus Biosciences, Inc..
  - Action: ceased to function as
  - Role: Principal Accounting Officer
  source text: Concurrent with Mr. Azoy’s appointment as the Company’s Principal Accounting Officer, Robert C. Goeltz II, the Company’s Chief Financial Officer (and in such role was the Company’s Principal Financial Officer), ceased to function as the Company’s Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm
- Executive change
  Alexander Azoy was appointed as Principal Accounting Officer at Arcus Biosciences, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On March 9, 2023, the Board of Directors (the “Board”) of Arcus Biosciences, Inc. (the “Company”) appointed Alexander Azoy to serve as the Company’s Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.